Breakthrough cancer pain (BTcP) is a common phenomenon, with a reported overall prevalence of ~60% in patients with cancer pain. It has a significant impact on quality of life, which relates not only to the pain itself, but also to the associated physical, psychological, and social problems. Equally, it has a significant impact on health systems (due to the increased use of healthcare resources).
BTcP is often misdiagnosed, and frequently mismanaged / undertreated. These on-line educational sessions will highlight the so- called "ART" of managing BTcP: A = adequate Assessment; R = adequate Re-assessment; T = appropriate Treatment (i.e. personalised treatment), and address often-asked questions by patients and their families about BTcP.
This course has been supported by an unrestricted educational grant from Angelini Pharma.
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
|Quantity||Price per voucher|
|Breakthrough Cancer Pain (BTcP)|
|What is BTcP?|
|How do you treat BTcP?|
|Commonly asked questions on BTcP|